Conventional and evolved platforms engineered to help you capitalize on the potential of your recombinant protein and monoclonal antibody (mAb) discoveries
Live viruses, viral vectors and other components (including infectivity and potency assays) to enable more efficient, effective vaccine development
Process and analytical development for viral vector productions and next-generation testing methods to take your innovation from starting material to product release
Modular manufacturing processes designed to leverage the most promising emerging technologies for blood and bone marrow-centered therapies
A powerful mRNA platform, integrated supply chain and solid-state chemistry capabilities to provide a more direct, holistic path forward from first concept
We do that by delivering three crucial advantages to your team:
Aligned incentives to accelerate development and to provide the investment, know-how and experience you need to optimize opportunities
Access to best-in-class development platforms derived from breakthroughs across five key modalities
A digital-first enterprise committed to delivering on the promise of cloud-based systems, advanced AI, and next-level visibility and data security
